Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any defects¿ or malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that patient had a surgical revision.This event is a serious adverse event and is noted to have causal relationship to implant procedure and/or vns device.It was later clarified the patient reported wound healing disorder on the left neck.According to the patient, purulent liquid had recently escaped from the wound.The patient had surgical procedure.The procedure was uncomplicated, intraoperatively there was no evidence of an infection.Nothing was changed on the generator and the electrode, ultimately nothing could be found intraoperatively that confirmed the information provided by the patient.Even the scars were harmless.There was no association with vns stimulation.It is unknown if the device is still implanted or if it was removed.No other relevant information has been received to date.
|
It was later reported that the surgical revision of vns had a causal relationship with implant and procedure.This was not related to stimulation/device, concomitant medication, primary condition being treated, or other medical condition.It was not an unanticipated serious adverse event.Action was taken in the form of surgery and the event has resolved and patient recovered.No other relevant information has been received to date.
|